Social media, blogs, and forums have proven to be the most important resource and platform for disease and illness-specific communities. Patients/caregivers use social networks and forums to seek solutions and share experiences, while advocates look to share treatment information and to provide support to the community at large. Effective implementation of Social Intelligence also helps important stakeholder groups – including healthcare professionals – to understand all the issues, pain points, and topics of importance that frequently engage the community in conversation.
In our on-demand webinar with Social Intelligence expert, Greg Roth (Synthesio, VP Global Marketing), provides pharma brands with guidelines for implementing a sustainable Social Intelligence framework at scale.
Synthesio was acquired by Ipsos in 2018, and remains a standalone Ipsos company. Ipsos was founded in 1975, has 18,000 employees, and is the leader in market research and consumer insights. Combined, Synthesio and Ipsos deliver world-class technology and services for Social Media Intelligence.
Paste or type content here to reinforce the CTA.
Your privacy is important to us.
Optionally paste or type content here.